270 related articles for article (PubMed ID: 26437214)
1. LIMITATIONS OF CURRENT APPROACHES FOR THE TREATMENT OF ACROMEGALY.
Shanik MH
Endocr Pract; 2016 Feb; 22(2):210-9. PubMed ID: 26437214
[TBL] [Abstract][Full Text] [Related]
2. Acromegaly.
Scacchi M; Cavagnini F
Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
[TBL] [Abstract][Full Text] [Related]
3. [Current diagnosis and treatment of acromegaly].
Melgar V; Espinosa E; Cuenca D; Valle V; Mercado M
Rev Med Inst Mex Seguro Soc; 2015; 53(1):74-83. PubMed ID: 25680646
[TBL] [Abstract][Full Text] [Related]
4. Pituitary tumours: acromegaly.
Chanson P; Salenave S; Kamenicky P; Cazabat L; Young J
Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):555-74. PubMed ID: 19945023
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of dose escalation and surgical debulking in patients with acromegaly treated with somatostatin analogs in a Romanian tertiary care center.
Gheorghiu ML; Găloiu S; Vintilă M; Purice M; Hortopan D; Dumitraşcu A; Coculescu M; Poiană C
Hormones (Athens); 2016 Apr; 15(2):224-234. PubMed ID: 27376425
[TBL] [Abstract][Full Text] [Related]
7. [Advances in the treatment of acromegaly].
Krysiak R; Okopień B; Marek B
Pol Merkur Lekarski; 2008 Jan; 24(139):59-65. PubMed ID: 18634256
[TBL] [Abstract][Full Text] [Related]
8. Treatment of persistent and recurrent acromegaly.
Del Porto LA; Liubinas SV; Kaye AH
J Clin Neurosci; 2011 Feb; 18(2):181-90. PubMed ID: 21167718
[TBL] [Abstract][Full Text] [Related]
9. Acromegaly.
Chanson P; Salenave S; Kamenicky P
Handb Clin Neurol; 2014; 124():197-219. PubMed ID: 25248589
[TBL] [Abstract][Full Text] [Related]
10. [Not Available].
Mosbah H; Brue T; Chanson P
Ann Endocrinol (Paris); 2019 Sep; 80 Suppl 1():S10-S18. PubMed ID: 31606057
[TBL] [Abstract][Full Text] [Related]
11. The place of medical treatment of acromegaly: current status and perspectives.
Jallad RS; Bronstein MD
Expert Opin Pharmacother; 2013 Jun; 14(8):1001-15. PubMed ID: 23600991
[TBL] [Abstract][Full Text] [Related]
12. Current management of acromegaly.
Díez JJ; Iglesias P
Expert Opin Pharmacother; 2000 Jul; 1(5):991-1006. PubMed ID: 11249504
[TBL] [Abstract][Full Text] [Related]
13. Long-term safety and treatment outcomes of pegvisomant in Japanese patients with acromegaly: results from the post-marketing surveillance.
Yamaguchi H; Shimatsu A; Okayama A; Sato T
Endocr J; 2020 Feb; 67(2):201-210. PubMed ID: 31723069
[TBL] [Abstract][Full Text] [Related]
14. Review of current and emerging treatment options in acromegaly.
Muhammad A; van der Lely AJ; Neggers SJ
Neth J Med; 2015 Oct; 73(8):362-7. PubMed ID: 26478545
[TBL] [Abstract][Full Text] [Related]
15. A registry of acromegaly patients and one year following up in Taiwan.
Tseng FY; Huang TS; Lin JD; Chen ST; Wang PW; Chen JF; Huey-Herng Sheu W; Chang TC;
J Formos Med Assoc; 2019 Oct; 118(10):1430-1437. PubMed ID: 30612883
[TBL] [Abstract][Full Text] [Related]
16. Management of endocrine disease: GH excess: diagnosis and medical therapy.
Andersen M
Eur J Endocrinol; 2014 Jan; 170(1):R31-41. PubMed ID: 24144967
[TBL] [Abstract][Full Text] [Related]
17. Paradoxical GH Increase During OGTT Is Associated With First-Generation Somatostatin Analog Responsiveness in Acromegaly.
Scaroni C; Albiger N; Daniele A; Dassie F; Romualdi C; Vazza G; Regazzo D; Ferraù F; Barresi V; Maffeis V; Gardiman MP; Cannavò S; Maffei P; Ceccato F; Losa M; Occhi G
J Clin Endocrinol Metab; 2019 Mar; 104(3):856-862. PubMed ID: 30285115
[TBL] [Abstract][Full Text] [Related]
18. Current treatment guidelines for acromegaly.
Melmed S; Jackson I; Kleinberg D; Klibanski A
J Clin Endocrinol Metab; 1998 Aug; 83(8):2646-52. PubMed ID: 9709926
[TBL] [Abstract][Full Text] [Related]
19. Therapy for the syndromes of GH excess.
Arosio M; Cannavò S; Epaminonda P; Ronchi C; Chiodini I; Adda G
J Endocrinol Invest; 2003; 26(10 Suppl):36-43. PubMed ID: 15497658
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological management of acromegaly: a current perspective.
Manjila S; Wu OC; Khan FR; Khan MM; Arafah BM; Selman WR
Neurosurg Focus; 2010 Oct; 29(4):E14. PubMed ID: 20887124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
